Forsta AP Fonden Reduces Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Forsta AP Fonden lessened its stake in shares of Avantor, Inc. (NYSE:AVTR) by 7.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 137,300 shares of the company’s stock after selling 11,300 shares during the quarter. Forsta AP Fonden’s holdings in Avantor were worth $2,911,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AVTR. Versant Capital Management Inc grew its stake in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after buying an additional 1,102 shares during the last quarter. Blue Trust Inc. grew its position in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the last quarter. TFO Wealth Partners LLC increased its holdings in shares of Avantor by 203,100.0% in the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after acquiring an additional 2,031 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new stake in Avantor in the 1st quarter valued at $93,000. Finally, ORG Partners LLC boosted its stake in Avantor by 5,773.0% during the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 1.5 %

Shares of AVTR opened at $26.88 on Monday. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $18.27 billion, a P/E ratio of 68.92, a PEG ratio of 2.75 and a beta of 1.32. The firm’s 50-day moving average is $24.42 and its two-hundred day moving average is $24.27.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, research analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on AVTR shares. TD Cowen lifted their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Royal Bank of Canada reiterated an “outperform” rating and issued a $31.00 target price on shares of Avantor in a research note on Monday, July 29th. Robert W. Baird upped their price target on Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Finally, Morgan Stanley lifted their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $27.40.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.50% of the company’s stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.